SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides.
SMS Pharmaceuticals Limited (SMSPHARMA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - General industry. The SMSPHARMA share price is ₹505.00 (-2.51% today), with a market capitalisation of ₹47B and a price-to-earnings (P/E) ratio of 44.9. MarketRipple tracks the SMSPHARMA investment thesis, the ripple-chain impact of market events on SMS Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹493.80
High
₹514.40
Low
₹493.80
Prev. Close
₹518.00
52W High
₹535.00
52W Low
₹270.10
Day range
₹493.80–₹514.40
52-week range
₹270.10–₹535.00
Volume
166K
P/E
44.9
ROE
13.0%
D/E
0.46
Margin
11.4%
SMS Pharmaceuticals Limited (NSE: SMSPHARMA) is currently trading at ₹505.00 (-2.51%).
SMS Pharmaceuticals Limited's market capitalization is ₹47B.
SMS Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 44.9.
SMS Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - General).